Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.42 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.42 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.42 |
| ▸ | S1PR5 | Q9H228 | 4/20 | 0.42 |
| ▸ | PGD | P52209 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.38 |
| ▸ | PGK1 | P00558 | 1/20 | 0.37 |
| ▸ | PGK2 | P07205 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4949000 | 1.00 | MEN1 (0.61) | MEN1KMT2ALPAR1LPAR2ENPP2 | |
| SCHEMBL13199295 | 0.82 | LPAR1 (0.43) | MEN1KMT2ALPAR1LPAR2ENPP2 | |
| SCHEMBL13924989 | 0.81 | LPAR1 (0.40) | MEN1KMT2ALPAR1LPAR2ENPP2 | |
| SCHEMBL13903932 | 0.81 | LPAR1 (0.40) | MEN1KMT2ALPAR1LPAR2ENPP2 | |
| SCHEMBL17327606 | 0.80 | MEN1 (0.70) | MEN1KMT2AUSP2TSHR | |
| SCHEMBL13985616 | 0.80 | LPAR1 (0.42) | MEN1KMT2ALPAR1LPAR2ENPP2 | |
| SCHEMBL15705547 | 0.77 | PTGS1 (0.58) | LPAR1LPAR2ENPP2S1PR1S1PR3 | |
| SCHEMBL17753845 | 0.76 | LPAR1 (0.46) | LPAR1LPAR2ENPP2LPAR3USP2 | |
| SCHEMBL13446146 | 0.75 | S1PR1 (0.40) | MEN1KMT2ALPAR1LPAR2ENPP2 | |
| SCHEMBL8533026 | 0.75 | KMT2A (0.67) | MEN1KMT2AUSP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025125392-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-06-19 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-1758468-B1 | TASTE IMPROVING SUBSTANCES | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2011-03-02 | — | — | EP | claimed |
| WO-2025125392-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-06-19 | — | — | WO | disclosed |
| EP-3606357-B1 | FLAVOR MODIFIERS FOR MEAT ANALOG PRODUCTS | GIVAUDAN SA (CH) | 2024-12-04 | — | — | EP | disclosed |
| US-20240277012-A1 | DUPLICATE BEVERAGE | WANG JIE (US) | 2024-08-22 | — | — | US | disclosed |
| US-12035733-B2 | Flavor modifiers for meat analog products | GIVAUDAN SA (CH) | 2024-07-16 | — | — | US | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-11758933-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2023-09-19 | — | — | US | disclosed |
| US-20230091950-A1 | Flavor Modifiers For Meat Analog Products | GIVAUDAN SA (CH) | 2023-03-23 | — | — | US | disclosed |
| US-11517036-B2 | Flavor modifiers for meat analog products | GIVAUDAN SA (CH) | 2022-12-06 | — | — | US | disclosed |
| EP-3368542-B1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11357246-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2022-06-14 | — | — | US | disclosed |
| CN-111343870-A | Perfume composition | 奇华顿股份有限公司 | 2020-06-26 | — | — | CN | disclosed |
| CN-106999973-A | System and method for discharging edible material | 阿甘芳香和精细化工有限公司 | 2017-08-01 | — | — | CN | disclosed |
| EP-1758468-B1 | TASTE IMPROVING SUBSTANCES | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2011-03-02 | — | — | EP | disclosed |
| EP-1758468-A1 | TASTE IMPROVING SUBSTANCES | Quest International Services B.V. (NL) | 2007-03-07 | — | — | EP | disclosed |
| WO-2005102071-A1 | TASTE IMPROVING SUBSTANCES | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | MEN1 2644/4885KMT2A 2697/4885LPAR1 3679/4885 |
| US-11357246-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | MEN1 2644/4885KMT2A 2697/4885LPAR1 3679/4885 |
| US-11758933-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | MEN1 2644/4885KMT2A 2697/4885LPAR1 3679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.